Journal Watch · Frontiers in Immunology · 2026

Diagnostic value of CSF CXCL8 combined with total protein for neurosyphilis: a logistic regression and ROC analysis.

The combined detection of CSF CXCL8 and CSF TP enhances diagnostic precision.

Zhang Y, Jin Y, Liu Y et al.Frontiers in Immunology3 min readPharma relevance 65/100

DOI: 10.3389/fimmu.2026.1806528PMID: 42317354Study type: clinical study

TL;DR

The combined detection of CSF CXCL8 and CSF TP enhances diagnostic precision.

Key findings

  • Binary logistic regression analysis identified CSF CXCL8 and CSF TP as independent predictors of neurosyphilis.
  • ROC curve analysis revealed areas under the curve (AUC) for CSF CXCL8 and CSF TP distinguishing neurosyphilis from syphilis of 0.766 and 0.830, respectively.
  • The combined assessment of CSF CXCL8 and CSF TP further improved diagnostic accuracy, with an AUC of 0.865.<h4>Conclusions</h4>The levels of CSF CXCL1 and CSF CXCL8 are valuable for diagnosing neurosyphilis and assessing treatment efficacy.
  • The combined detection of CSF CXCL8 and CSF TP enhances diagnostic precision.

Numbers at a glance (from the abstract)

P < 0.05

Every figure above is taken verbatim from the abstract below. Check the full text for denominators, confidence intervals and subgroup detail.

What they did

Univariate and multivariate logistic regression analyses were conducted to identify predictors of neurosyphilis. Receiver operating characteristic (ROC) curve analysis was employed to evaluate the diagnostic value of individual and combined biomarkers for this condition.<h4>Results</h4>CSF CXCL1 and CSF CXCL8 levels were significantly elevated in the neurosyphilis group compared to the syphilis group (P < 0.05). Additionally, CSF white cell count (CSF WBC) and CSF total protein (CSF TP) levels were increased, while CD4 levels were decreased.

Full abstract (original)

Background: <h4>Background</h4>Neurosyphilis has resurged globally, presenting a significant public health threat, yet challenges in early diagnosis persist. This study aims to evaluate the diagnostic value of C-X-C motif chemokine ligand 1 (CXCL1), C-X-C motif chemokine ligand 5(CXCL5), and C-X-C motif chemokine ligand 8 (CXCL8) in cerebrospinal fluid (CSF) for neurosyphilis.<h4>Methods</h4>A total of 126 patients were included in this study, comprising 44 syphilis patients and 82 diagnosed with neurosyphilis (28 asymptomatic and 54 symptomatic). We assessed CSF chemokines, CSF parameters, and lymphocyte subpopulations.

What they did: Univariate and multivariate logistic regression analyses were conducted to identify predictors of neurosyphilis. Receiver operating characteristic (ROC) curve analysis was employed to evaluate the diagnostic value of individual and combined biomarkers for this condition.<h4>Results</h4>CSF CXCL1 and CSF CXCL8 levels were significantly elevated in the neurosyphilis group compared to the syphilis group (P < 0.05). Additionally, CSF white cell count (CSF WBC) and CSF total protein (CSF TP) levels were increased, while CD4 levels were decreased.

Results & conclusions: Binary logistic regression analysis identified CSF CXCL8 and CSF TP as independent predictors of neurosyphilis. ROC curve analysis revealed areas under the curve (AUC) for CSF CXCL8 and CSF TP distinguishing neurosyphilis from syphilis of 0.766 and 0.830, respectively. The combined assessment of CSF CXCL8 and CSF TP further improved diagnostic accuracy, with an AUC of 0.865.<h4>Conclusions</h4>The levels of CSF CXCL1 and CSF CXCL8 are valuable for diagnosing neurosyphilis and assessing treatment efficacy. The combined detection of CSF CXCL8 and CSF TP enhances diagnostic precision.

Abstract © the authors / Frontiers in Immunology (2026). Reproduced here for discussion and indexing, with attribution. Read the original at https://doi.org/10.3389/fimmu.2026.1806528 · PubMed 42317354.

Why it matters for pharma & biotech

  • Relevant to Immunology teams tracking Frontiers in Immunology for new targets, mechanisms and biomarkers.
  • Because it reports human data, it can inform indication, endpoint and comparator decisions faster than preclinical work.
  • For searchers: the full abstract is reproduced below, so you can judge relevance before opening the publisher page.

Limitations & what to check in the full text

  • This brief is based on the published abstract only. Effect sizes, subgroup results and safety detail in the full text may qualify the headline findings.

Frequently asked questions

What did this Frontiers in Immunology study find?

The combined detection of CSF CXCL8 and CSF TP enhances diagnostic precision.

What type of study is this?

It is a clinical study, published in Frontiers in Immunology in 2026. Univariate and multivariate logistic regression analyses were conducted to identify predictors of neurosyphilis.

Where can I read the original paper?

The original is at the publisher via DOI 10.3389/fimmu.2026.1806528. PubMed ID: 42317354. BioStudioAI reproduces the abstract for discussion and links to the source.

How to cite the original: Zhang Y, Jin Y, Liu Y et al.. Diagnostic value of CSF CXCL8 combined with total protein for neurosyphilis: a logistic regression and ROC analysis.. Frontiers in Immunology (2026). DOI: 10.3389/fimmu.2026.1806528.
This brief: BioStudioAI Journal Watch, 29 October 2026. https://biostudioai.com/blog/papers/diagnostic-value-of-csf-cxcl8-combined-with-total-protein-for-neurosyphi-806528/

Reading papers is step one. Analysing the data is the work.

BioStudioAI turns raw lab files into QC'd results, statistics, figures, reports and slides — hosted on your servers, every number computed, nothing typed.

Open BioStudioAI More guides